We found that both CD4+ T cells (defined as CD45+ CD3+ CD4+) as well as CD8+ T cells (defined as CD45+ CD3+ CD8+) showed increased IL22bp expression in HCC compared to control (Figure 3E). This evidence concerns the gene IL22RA2 and hepatocellular carcinoma.